Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Common arthritis drugs may weaken bones, new study warns

NCT ID NCT06812481

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times

Summary

This study explores whether medications with anticholinergic effects increase the risk of bone fractures in people with rheumatoid arthritis. Researchers will track 100 patients, measuring their anticholinergic load and using the FRAX tool to estimate fracture risk. The goal is to better understand how these drugs impact bone health, helping doctors make safer prescribing decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Balikesir University Health Practice and Research Hospital

    RECRUITING

    Balıkesir, 10145, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.